Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis

被引:0
|
作者
Necat Yılmaz
Esin Eren
机构
[1] Education and Research Hospital of Antalya and Gaziantep University Medical School,Department of Biochemistry
[2] Center of Public Health and Women’s Health Laboratory,Department of Biochemistry and Clinical Chemistry
[3] Education and Research Hospital of Antalya,undefined
关键词
Antioxidant; deoxypyridinoline; DEXA; homocysteine; osteoporosis;
D O I
暂无
中图分类号
学科分类号
摘要
Background and aims: Mildly elevated homocysteine (Hcy) and oxidative stress are novel and potentially modifiable risk factors for post-menopausal osteoporosis. We hypothesized that imbalance of oxidant/antioxidant status and increased Hcy concentration stimulates osteoporotic activity, leading to increased collagen I breakdown in post-menopausal women. Methods: Patients were divided into 2 groups (NOP and OP). Group NOP had normal bone mineral density (BMD) and group OP low BMD. Thirty-four (69%) were in group OP and 15 (31%) in group NOP. Serum Total Antioxidant Status (TAS) and Total Peroxide (TPx) levels were determined with new automated methods. The study included measurement of Deoxypyridinoline (DPD). Results: In OP patients plasma t-Hcy, urine deoxypyridinoline and plasma TPx were significantly higher than those in NOP controls. In addition, OP patients also had lower TAS levels than controls, which represent the oxidative imbalance. Pearson’s correlation analysis revealed a negative correlation between t-Hcy and TAS (p<0.038). A significant negative correlation was also found between TAS level and BMD values for the spine in OP patients (p<0.035). In contrast, a positive correlation between t-Hcy and TPx in OP patients was demonstrated significantly, r=0.52, p<0.029. Conclusions: We show that the OP group had reduced TAS, whereas the elevated TPx was different from that in the NOP group. Slightly elevated homocysteinemia may contribute to increasing TPx and reducing TAS in the OP group. However, our results suggest a weak but negative relationship between TAS and BMD. Further investigations are needed to examine the relationship of oxidative stress as an endogenous bioactive agent to bone loss in post-menopausal women. Since oxidative stress is the imbalance between total oxidants and antioxidants in the body, any single oxidant/antioxidant parameter may not reflect overall oxidative stress. Further studies are needed to understand the underlying mechanisms of these findings.
引用
收藏
页码:353 / 357
页数:4
相关论文
共 50 条
  • [1] Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis
    Yilmaz, Necat
    Eren, Esin
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 21 (4-5) : 353 - 357
  • [2] Bone mineral density and serum osteoprotegerin in post-menopausal women with or without osteoporosis
    Ardawi, M. S.
    Nasrat, H. A.
    Bahksh, T. M.
    Maimany, A. A.
    Rouzi, A. A.
    [J]. BONE, 2007, 40 (06) : S193 - S194
  • [3] The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women
    Bucciarelli, Paolo
    Martini, Giuseppe
    Martinelli, Ida
    Ceccarelli, Elena
    Gennari, Luigi
    Bader, Rossella
    Valenti, Roberto
    Franci, Beatrice
    Nuti, Ranuccio
    Mannucci, Pier Mannuccio
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (04) : 301 - 305
  • [4] OXIDATIVE STRESS AND RELATION TO BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS
    Baykal, T.
    Senel, K.
    Seferoglu, B.
    Kiziltunc, A.
    Ugur, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 299 - 299
  • [5] Serum Osteoprotegerin and Bone Mineral Density in Post-Menopausal Women with or without Osteoporosis.
    Rouzi, Abdulrahim A.
    Ardawi, Mohammed S.
    Baksh, Talal M.
    Maimany, Abdulraof A.
    Qari, Mohammed H.
    [J]. REPRODUCTIVE SCIENCES, 2010, 17 (03) : 269A - 269A
  • [6] BONE-MATRIX AND MINERAL ABNORMALITIES IN POST-MENOPAUSAL OSTEOPOROSIS
    BURNELL, JM
    BAYLINK, DJ
    CHESTNUT, CH
    MATHEWS, MW
    TEUBNER, EJ
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (11): : 1113 - 1120
  • [7] Serum Osteocalcin and Bone Mineral Density as Markers of Post-menopausal Osteoporosis: A Meta-analysis
    Tirthal, Rai
    Usha, Adiga
    Rishabh, Hegde
    [J]. RESEARCH JOURNAL OF BIOTECHNOLOGY, 2021, 16 (12): : 173 - 184
  • [8] THE EFFECT OF 90 mg OF PAMIDRONATE GIVEN ANNUALLY ON BONE MINERAL DENSITY IN POST-MENOPAUSAL OSTEOPOROSIS
    Thomas, E. W.
    Cohen, H.
    Morgan, J.
    Hampton, D.
    Martin, J. C.
    [J]. RHEUMATOLOGY, 2004, 43 : 61 - 61
  • [9] Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis
    OrrWalker, B
    Wattie, DJ
    Evans, MC
    Reid, IR
    [J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (01) : 87 - 92
  • [10] LUMBAR SPINE BONE-MINERAL CONTENT IN POST-MENOPAUSAL OSTEOPOROSIS
    KROLNER, B
    NIELSEN, SP
    LUND, B
    LUND, B
    SORENSEN, OH
    JACOBSEN, S
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1980, 31 (01) : 63 - 63